|
UVRAG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.967940E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.393110E-04 |
| Normal-vs-Stage2 |
9.593600E-02 |
| Normal-vs-Stage3 |
5.782000E-01 |
| Normal-vs-Stage4 |
4.404200E-01 |
| Stage1-vs-Stage2 |
6.965400E-01 |
| Stage1-vs-Stage3 |
4.172800E-04 |
| Stage1-vs-Stage4 |
9.581700E-04 |
| Stage2-vs-Stage3 |
5.916300E-02 |
| Stage2-vs-Stage4 |
4.149700E-02 |
| Stage3-vs-Stage4 |
7.848800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.199900E-02 |
| Normal-vs-AfricanAmerican |
4.913200E-01 |
| Normal-vs-Asian |
2.475400E-01 |
| Caucasian-vs-AfricanAmerican |
6.377800E-01 |
| Caucasian-vs-Asian |
3.982000E-01 |
| AfricanAmerican-vs-Asian |
3.442000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.060160E-01 |
| Normal-vs-Female |
9.336400E-03 |
| Male-vs-Female |
1.960810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.701600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.702950E-03 |
| Normal-vs-Age(61-80Yrs) |
2.417200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.494400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.673900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.623200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.324200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.169500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.464000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.876200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.035800E-03 |
| Normal-vs-Grade 2 |
1.972670E-04 |
| Normal-vs-Grade 3 |
4.269200E-01 |
| Normal-vs-Grade 4 |
5.877700E-02 |
| Grade 1-vs-Grade 2 |
5.354000E-04 |
| Grade 1-vs-Grade 3 |
4.442000E-03 |
| Grade 1-vs-Grade 4 |
4.34569999985257E-07 |
| Grade 2-vs-Grade 3 |
4.743000E-03 |
| Grade 2-vs-Grade 4 |
2.03189999999909E-05 |
| Grade 3-vs-Grade 4 |
1.593700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.92870003196322E-09 |
| Normal-vs-ccB subtype |
3.306200E-01 |
| ccA subtype-vs-ccB subtype |
2.5464996777913E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.884400E-02 |
| Normal-vs-N1 |
2.047000E-01 |
| N0-vs-N1 |
5.010100E-02 |
|
|
